ADArunava Das

Arunava Das

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arunava Das has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and Validation of a Liquid Chromatography–Electrospray Ionization–Tandem Mass Spectrometry Method for the Determination of Alpelisib, a Novel Phosphatidylinositol 3-Kinase Inhibitor, and Its Application to a Pharmacokinetic Study in Mice

    by Abhishek Dixit, Arunava Das

    Alpelisib (BY719) is a phosphoinositide-3-kinase inhibitor that specifically targets phosphoinositide-3-kinase-alpha. This enzyme is part of the phosphoinositide-3-kinase/α-serine/threonine-protein kinase/mammalian target of rapamycin signaling pathway, which promotes cell growth and survival. Mutations in the phosphoinositide-3-kinase gene cause the phosphoinositide-3-kinase signaling pathway to become overactive, leading to uncontrolled cell growth and survival, which contributes to tumor development. By inhibiting phosphoinositide-3-kinase-alpha, alpelisib can slow tumor growth and kill cancer cells. The goal of this study was to develop and validate a new, sensitive, specific, and rapid liquid chromatography–tandem mass spectrometry method for measuring alpelisib in dried blood spots from both mice and humans. Filgotinib served as the internal standard, and all procedures adhered to regulatory standards. Alpelisib and the internal standard were measured using a Sciex triple quadrupole mass spectrometer in multiple reaction monitoring mode with positive-ion detection. The focus was on the parent–daughter mass-to-charge transitions of m/z 442.0→327.9 for alpelisib and m/z 426.2→291.2 for the internal standard. The linear range for alpelisib was 0.331–1026 ng/mL (r>0.990). This method successfully characterized the in vitro metabolic profiles and in vivo pharmacokinetics of alpelisib in mice. A strong correlation was found between dried blood spots and plasma concentrations, suggesting that dried blood spots can serve as an alternative to plasma for pharmacokinetic analysis.

  • Quantitation of Tucatinib, a Novel Tyrosine Kinase Inhibitor in Dried Blood Spot (DBS) With LC‐ESI‐MS/MS: Application to a Pharmacokinetic Study in Mice

    by Abhishek Dixit, Arunava Das

    Tucatinib (Irbinitinib, ARRY‐380), a potent oral, selective HER2 kinase inhibitor that the FDA, has approved for the treatment of HER2‐positive metastatic breast cancer and colorectal cancer. Tucatinib provides a powerful, targeted therapy for HER2‐positive cancers, showing substantial benefits in survival and disease control, especially for patients with difficult‐to‐treat brain metastases, extending options beyond standard chemotherapy. This research aimed to create and validate a new rapid, sensitive, and specific LC–MS/MS technique for measuring tucatinib in dried blood spots (DBS) from mice, with afatinib serving as an internal standard (IS) following regulatory guidelines in the linearity range from 0.178 to 1009 ng/mL ( r > 0.990). The chromatographic separation of tucatinib and IS was achieved using the Acquity BEH C18 column with an isocratic mobile phase at a flow rate of 0.6 mL/min within 1.15 min total run time and 2 μL injection volume. Detection and quantification of tucatinib and the IS was done by using a triple quadrupole mass spectrometer in multiple reaction monitoring (MRM) mode. Tucatinib remained stable under various storage conditions. Comparison of DBS versus plasma samples concentrations showed a strong correlation, suggesting that DBS can serve as a valid alternative to plasma for pharmacokinetic evaluation.

  • Prevalence of Clostridium perfringens Type a Isolated from Diarrheic Stray Cattle in Mandsaur, Madhya Pradesh

    by Kundan Mali, Arunava Das

    Clostridium perfringens is often responsible for gut-related illnesses in livestock. During present investigation fecal samples of eight diarrheic stray cattle were examined in Mandsaur district (Madhya Pradesh). Pure isolates of bacterial pathogens were isolated and their morphological and biochemical characters were studied. All of the isolates were Gram-positive, spore-producing rods. They were found to be creating alpha and beta hemolysis zones on sheep blood plates. Isolated bacteria also broke down gelatin and lecithin, produced DNAase enzyme, while metabolizing sugars like glucose, lactose, galactose, and milk at the temperature of 37°C. Their molecular screening highlighted alpha toxin gene (cpa) at 324 base pairs in all cases, with no signals for other major toxins.

  • Prevailance of Bacteriocin Producing Lactobacillus plantarum in Dairy Products from Mandsaur, Madhya Pradesh

    by Cheena Taly, Arunava Das

    Lactobacillus plantarum, serves as a primary component in probiotic formulations. Present study explored its occurrence in dairy products collected from Mandsaur district of Madhya Pradesh. For this purpose, 18 dairy samples were screened to detect L. plantarum, as a result of which 12 isolates of L. plantarum were obtained. Their genomic DNA extraction, followed by PCR were then tested for bacteriocin production against common food-spoilage bacteria. All isolates appeared Gram-positive, rod-shaped, and non-motile. They efficiently fermented sugars such as galactose, lactose, mannitol, sorbitol, and raffinose. Their peak growth was obtained at pH 5.5 and 37°C, with good tolerance to varying bile salt levels. In all 12 isolates were found to be positive against L. plantarum, out of which L13 strain showed highest bacteriocin activity, resulting into 18 mm wide zone of inhibition against Staphylococcus aureus. The findings thus highlighted abundant bacteriocin producing L. plantarum in local dairy items.

  • Determination of Zipalertinib Using LC‐ESI‐MS/MS and Application to Pharmacokinetic Study in Mice

    by Abhishek Dixit, Arunava Das

    Zipalertinib is a novel, irreversible EGFR inhibitor for the treatment of non‐small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. A new sensitive, specific and rapid LC‐ESI‐MS/MS method has been developed and validated to quantify zipalertinib in mouse and human dried blood spot (DBS) with filgotinib used as an internal standard (IS) in accordance with regulatory guidelines. Quantification of zipalertinib and IS were achieved by triple quad mass spectrometer operated under the multiple reaction‐monitoring mode (MRM) using positive ion scan mode and parent‐daughter mass to charge ion transition of m/z 397.2 → 326.0 and m/z 426.2 → 291.2, respectively. The linear response function of zipalertinib was determined in the concentration range from 0.741 to 1111 ng/mL (r > 0.990). No matrix effect and carry over were observed. Hematocrit did not influence DBS zipalertinib concentrations. Zipalertinib demonstrated stability under various storage conditions. This method was successfully used to study the in vitro metabolic profiles and in vivo pharmacokinetics of zipalertinib in mice. An excellent correlation was observed between DBS and plasma concentrations, indicating DBS can be used as an alternative for plasma for pharmacokinetic analysis.

  • In silico approaches for consensus primer design and validation towards development of rapid diagnostics against the Candidatus Liberibacter species

    by Butwall S, DAS A

    Citrus greening or Huanglongbing (HLB) is a rapidly spreading disease caused by Candidatus Liberibacter species, which inhabit the phloem of citrus plants. It is primarily transmitted by psyllid insects. Managing HLB is challenging due to the bacterium's phloem-restricted nature, making diagnosis and treatment with antimicrobials difficult. Here in the present study, the bacterial consensus sequences were used for the primer design with In silico approaches and validated by PCR. The study was carried out in the Malwa region of Madhya Pradesh, India, which is known for citrus cultivations and remains affected by the HLB disease. Phylogenetic analysis of 100 Candidatus Liberibacter 16S rRNA sequences from NCBI was conducted using MEGA 6, with Malwa-specific refinement via MAFFT alignment. Eight previously deposited sequences formed the basis for the study. A consensus sequence was derived and used to design region-specific primers with GeneFisher. PCR validation was carried out with standard thermal cycling and gel electrophoresis. Phylogenetic analysis of 100 Candidatus Liberibacter 16S rRNA sequences from NCBI was conducted using Phylogenetic analysis showed high genetic variation among Liberibacter strains, supporting the need for region-specific detection. Eight sequences from the Malwa region were aligned using BioEdit, confirming conserved primer sites. Consensus primers were designed using GeneFisher and optimized for 16S rRNA targets. PCR validation identified 22 positives out of 100 samples, with primer set 2 detecting all target species effectively. The study concludes that primer set 2 enables rapid and accurate detection of HLB-causing bacteria in the Malwa region.

  • Solvent selection for Extraction of Charantin in bitter gourd and comparative quantification by Reverse Phase High Performance Liquid Chromatography (RP-HPLC)

    by Gajanan Solunke, Arunava Das

    Many of the vegetable crops contain various health-promoting and bio-pharmaceutical nutrients. Bitter gourd (Momordica charantia L) is one of them, which contains many health-promoting phytomolecules. Each individual phytomolecule is useful for one or more deficiencies or diseases. Bitter gourd consists of more than 60 important phytonutrients, making it a functional food for regulating health. Most importantly, bitter gourd contains charantin, which consists of two glucosides, namely stigmasterol and sitosterol, which are effective against diabetes mellitus type II (DM2). Charantin is a micromolecule, so it is important to extract, quantify and formulate it to achieve an optimal dosage against diabetes. In the present study, the initial focus was on selecting a suitable solvent for maximizing charantin extraction from the dry fruit powder of bitter gourd. extraction with an organic solvent is important, and we have chosen methanol for extraction because it is polar, has a high boiling point, is available, etc. There are different extraction methods like ultra sonication, CO2 extraction, and water bath, but we used the Soxhlet extraction method. All three extracts are quantified by reverse phase high performance liquid chromatography (RP- HPLC). Charantin ranges 196 ug/g to 664 ug/ g, 283 to 927 ug/g and 159 to 780ug/g dry weight in absolute ethanol, absolute methanol and 1:1 mixture of ethanol and methanol respectively. Among these three combinations, methanol was found to be the most suitable solvent for extraction of maximum amount of charantin than ethanol and its combination.

  • Standardization and selection of organic solvent and extraction parameters for charantin in bitter gourd (Momordica charantin L.) fruits

    by Gajanan J. Solunke, Arunava DAS

    Standardization and selection of organic solvent and extraction parameters for charantin in bitter gourd (Momordica charantin L.) fruits Journals are one of the best online open access journal site in the field of publishing research articles in Agricultural, animal, dairy, food, home, legume Research Journals on a Global platform.

  • Development of a high-performance liquid chromatography (HPLC) method for analysis of charantin in bitter gourd (Momordica charantia) fruits

    by Gajanan J. Solunke, Arunava DAS

    Horticultural plants such as the bitter gourd (Momordica charantia L., family Cucurbitaceae) have a special significance as a vegetable in the kitchen and offer health benefits. Bitter gourd is cultivated in several tropical regions of Asian countries and in parts of Africa, Central North America, South North Asia, Singapore, Japan, etc. The main objective of this study is to develop a modified and validated high performance method for the quantification of charantin. Bitter gourd is rich in various phytomolecules, including charantin as an antidiabetic agent. Charantin is one of these phytomolecules that acts as an antidiabetic agent in type 2 diabetics. Charantin has a high molecular weight so that it is easily digested when taken orally. A validated and modified high performance liquid chromatography method was used for the quantification of charantin in bitter gourd fruits. Bitter gourd plants transplanted in Kharif 2023 from Mandsaur University Nursery, Mandsaur Campus were used for modification of extraction parameters and for carrying out the validated protocol in Kharif 2023. The fruits were harvested 60-65 days after planting in June/July 2022. Charantin extraction was done using methanol in Soxhlet and analysis was done using modified high performance liquid chromatography for quantification. C18 columns as stationary phase and methanol:water (98:2) were used for separation and quantification of charantin. Validated method for the analysis and separation of charantin in dry powder of bitter gourd fruits. Analysis and quantification were performed using the methanolic extract and yielded a content of 200-600 ug/g dry fruit weight. The high charantin variety can be used for further breeding purposes or directly for product formulation and basic clinical trials if required.

  • Method development and validation for the estimation of gedatolisib in mouse plasma by tandem mass spectrometry and its application to pharmacokinetics studies

    by Vinod A B, Arunava Das

    A simple and a sensitive liquid chromatography–tandem mass spectrometry method was developed and validated for the quantification of gedatolisib in mouse plasma. The extraction technique involved a simple precipitation method to extract gedatolisib and idelalisib (internal standard) from mouse plasma. A clean chromatographic separation of gedatolisib and the internal standard was achieved on an Atlantis dC18 column using an isocratic mobile phase (10 mm ammonium formate and acetonitrile; 30:70% v/v, both supplemented with 0.1% formic acid) delivered at a flow rate of 0.7 ml/min. The total run time was 2.0 min, and gedatolisib and idelalisib were eluted at 0.80 and 0.95 min, respectively. Gedatolisib was monitored at m/z 616.40 → 488.20 and idelalisib at 416.05 → 176.10. All the required parameters for the method validation were performed as per US Food and Drug Administration guidelines, and the results were within the acceptance criteria. The method was accurate and proved to be precise at a linearity range of 1.33–2667 ng/ml. The accuracy for gedatolisib in mouse plasma was in the ranges 0.99–1.06% (intra‐day) and 0.96–1.04% (inter‐day). Gedatolisib appeared to be stable in a series of stability conditions. Gedatolisib showed a good intravenous profile when administered through a solution formulation.